GPs are invited to attend a free webinar that will outline upcoming legal and regulatory changes to nicotine and considerations for prescribers.
An overview of the legal and regulatory framework for prescribing nicotine vaping products in Australia after 1 October will be provided. The evidence on nicotine vaping products and their place in treatment for smoking cessation care will be summarised, as will key clinical practice considerations for prescribing nicotine vaping products
When: Wednesday 8th September 2021 6:30pm-7:30pm
Presenters include:
Prof John Skerritt, Deputy Secretary, Health Products Regulation Group
Prof Nick Zwar, Executive Dean, Faculty of Health Sciences and Medicine, Bond University, Queensland, and Chair, Expert Advisory Group, RACGP Smoking cessation guidelines
Topics for discussion include:
Legal and regulatory framework for NVPs in Australia
TGA rescheduling decision for nicotine- overview and rationale
Prescribing pathways for nicotine vaping products
Nicotine vaping products
Overview of efficacy and safety evidence for nicotine vaping products
Role of NVPs in smoking cessation
Considerations for prescribers
Note: This event is open only to health professionals registered to practice in Australia. Employees and representatives of companies that manufacture, distribute or sell nicotine vaping or tobacco products are not permitted to register. Representatives of companies which provide strategic, PR, legal or any other professional services to any company that manufactures, distributes or sells nicotine vaping or tobacco products are also not permitted to register.
